The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
GOG3069: Phase 2 study of alpelisib and fulvestrant for PIK3CA-mutated estrogen receptor (ER)-positive endometrioid endometrial cancers.
 
Stephanie Gaillard
Consulting or Advisory Role - Immunogen; Merck; Verastem
Research Funding - AstraZeneca (Inst); Blueprint Pharmaceutic (Inst); Clovis Oncology (Inst); Compugen (Inst); Genentech/Roche (Inst); Immunogen (Inst); Iovance Biotherapeutics (Inst); Pfizer (Inst); Tempest Therapeutics (Inst); Tesaro (Inst)
Patents, Royalties, Other Intellectual Property - United States Patent Nos 10,258,604 & 10,905,659, licensed by Duke University to Sermonix (Inst)
 
Michael Sill
Employment - Roswell Park Cancer Institute
Consulting or Advisory Role - MD Anderson Cancer Center
 
Jennifer Klein
No Relationships to Disclose
 
Thomas Reid
No Relationships to Disclose
 
Michael Callahan
No Relationships to Disclose
 
Julia Fehniger
Consulting or Advisory Role - GlaxoSmithKline
 
Janelle Sobecki
No Relationships to Disclose
 
Michael A. Gold
Travel, Accommodations, Expenses - ASCCP
 
Thomas J Herzog
Leadership - GOG Foundation
Consulting or Advisory Role - AADi; AstraZeneca; Caris Life Sciences; Clovis Oncology; Corcept Therapeutics; Eisai; Epsilogen; Genentech; GlaxoSmithKline; JJ Innovative Medicine; Merck; Seagen
 
Brian M. Slomovitz
Consulting or Advisory Role - AstraZeneca; BioNTech SE; Eisai; EQRx; Genentech; Genmab; Gilead Sciences; GlaxoSmithKline; GOG Foundation; Lilly; Merck; Nuvation Bio; Onconova Therapeutics; Onconova Therapeutics; Regeneron; Seagen
 
Ursula A. Matulonis
Honoraria - Alkermes; Symphogen
Consulting or Advisory Role - Agenus; Allarity Therapeutics; Blueprint Medicines; Boehringer Ingelheim; Curelab Oncology; Eisai; GlaxoSmithKline; GlaxoSmithKline; Immunogen; Lilly; Merck; NextCure; ProfoundBio; Tango Therapeutics
Speakers' Bureau - Med Learning Group
Research Funding - Fujifilm; Immunogen; Leap Therapeutics; Merck; Mersana; Novartis; SQZ Biotech; Syndax; Tesaro
Travel, Accommodations, Expenses - AstraZeneca; Immunogen